CIK 0001000694
- Large accelerated filer
NOVAVAX INC
Sign in to watch- Ticker
- NVAX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 222816046
- Phone
- +1 240-268-2000
- Business address
- 21 FIRSTFIELD RD, GAITHERSBURG, MD
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-01 | Casey Mark J EVP, Chief Legal Officer | Shares withheld for taxes | −1,214 | $10.14 | $12K | 63,945 |
| 2026-03-01 | Casey Mark J EVP, Chief Legal Officer | Option exercise · Restricted Stock Units | −4,000 | 4,000 | ||
| 2026-01-23 | Jacobs John C President and CEO | Option exercise | +83,197 | 219,929 | ||
| 2026-01-23 | Jacobs John C President and CEO | Shares withheld for taxes | −39,132 | $9.17 | $359K | 180,797 |
| 2026-01-23 | Jacobs John C President and CEO | Option exercise · Restricted Stock Units | −83,197 | 0 | ||
| 2025-12-11 | Casey Mark J EVP, Chief Legal Officer | Option exercise | +41,899 | 73,972 | ||
| 2025-12-11 | Casey Mark J EVP, Chief Legal Officer | Shares withheld for taxes | −12,713 | $6.69 | $85K | 61,159 |
| 2025-12-11 | Casey Mark J EVP, Chief Legal Officer | Option exercise · Restricted Stock Units | −41,899 | 41,899 | ||
| 2025-11-11 | Draghia-Akli Ruxandra Section 16 | Option exercise | +14,257 | 14,257 | ||
| 2025-11-11 | Draghia-Akli Ruxandra Section 16 | Shares withheld for taxes | −6,048 | $7.40 | $45K | 8,209 |
| 2025-11-11 | Draghia-Akli Ruxandra Section 16 | Returned to the company · Restricted Stock Units | −14,257 | 28,513 | ||
| 2025-10-29 | Rodgers Richard J Director | Option exercise | +3,800 | 28,490 | ||
| 2025-10-29 | Rodgers Richard J Director | Option exercise · Restricted Stock Units | −3,800 | 0 | ||
| 2025-06-20 | Rodgers Richard J Director | Grant or award · Stock Option (Right to Buy) | +28,326 | $6.42 | $182K | 28,326 |
| 2025-06-20 | Rodgers Richard J Director | Grant or award · Restricted Stock Units | +18,884 | 18,884 | ||
| 2025-06-20 | MOTT DAVID M Director | Grant or award · Stock Option (Right to Buy) | +28,326 | $6.42 | $182K | 28,326 |
| 2025-06-20 | MOTT DAVID M Director | Grant or award · Restricted Stock Units | +18,884 | 18,884 | ||
| 2025-06-20 | King Rachel K. Director | Grant or award · Stock Option (Right to Buy) | +28,326 | $6.42 | $182K | 28,326 |
| 2025-06-20 | King Rachel K. Director | Grant or award · Restricted Stock Units | +18,884 | 18,884 | ||
| 2025-06-20 | DOUGLAS RICHARD Director | Grant or award · Stock Option (Right to Buy) | +28,326 | $6.42 | $182K | 28,326 |
Page 5 of 14 · 279 trades